Corrigendum to Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection [Biochem. Biophys. Res. Commun. 423 (2012) 867-872]
Biochemical and Biophysical Research Communications. Vol.432, No.1 (2013), 200-201
Suggested Citation
Chayanee Setthapramote, Tadahiro Sasaki, Orapim Puiprom, Kriengsak Limkittikul, Pannamthip Pitaksajjakul, Chonlatip Pipattanaboon, Mikiko Sasayama, Pornsawan Leuangwutiwong, Weerapong Phumratanaprapin, Supat Chamnachanan, Teera Kusolsuk, Akanitt Jittmittraphap, Azusa Asai, Juan Fernando Arias, Itaru Hirai, Motoki Kuhara, Yoshinobu Okuno, Takeshi Kurosu, Pongrama Ramasoota, Kazuyoshi Ikuta Corrigendum to Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection [Biochem. Biophys. Res. Commun. 423 (2012) 867-872]. Biochemical and Biophysical Research Communications. Vol.432, No.1 (2013), 200-201. doi:10.1016/j.bbrc.2013.01.107 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/31361
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Corrigendum to Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection [Biochem. Biophys. Res. Commun. 423 (2012) 867-872]
